Raiss R X, Karbowski A, Aigner T, Schleyerbach R
Biomedical Research PGE Rheumatology, Hoechst AG Werk Kalle-Albert, Wiesbaden, Germany.
J Rheumatol Suppl. 1995 Feb;43:152-4.
Effects of antirheumatic drugs upon cartilage matrix metabolism have been studied in a variety of chondrocyte in vitro systems. When compared longterm in 60 experiments under standardized conditions, articular chondrocytes cultured in agarose exhibit variability in proteoglycan synthesis, and its suppression by interleukin 1 (IL-1), but a high reproducibility in the modulation of these effects by antirheumatic drugs. Pentosan polysulfate, tenidap, tiaprofenic acid, and RO 31-9790 all compensated to a certain extent the IL-1 induced suppression of matrix synthesis in bovine chondrocytes, but only for tiaprofenic acid could this be confirmed using chondrocytes of human origin. Culture conditions as well as species differences should therefore be considered carefully when chondrocyte cultures are used as pharmacological models.
抗风湿药物对软骨基质代谢的影响已在多种软骨细胞体外系统中进行了研究。在60项标准化条件下的长期实验中进行比较时,琼脂糖中培养的关节软骨细胞在蛋白聚糖合成方面存在变异性,以及其受白细胞介素1(IL-1)抑制的变异性,但抗风湿药物对这些效应的调节具有高度可重复性。戊聚糖多硫酸盐、替硝唑、噻洛芬酸和RO 31-9790都在一定程度上补偿了IL-1诱导的牛软骨细胞基质合成抑制,但只有噻洛芬酸在人源软骨细胞中得到了证实。因此,当将软骨细胞培养用作药理模型时,应仔细考虑培养条件以及物种差异。